LUMEBLUE

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug LUMEBLUE contains one active pharmaceutical ingredient (API):

1 Methylthioninium chloride UNII 8NAP7826UB - METHYLENE BLUE ANHYDROUS

In vivo, in low concentration, methylthioninium chloride speeds up the conversion of methaemoglobin to haemoglobin. Methylthioninium chloride has been observed to stain tissues selectively. Read about Methylthioninium chloride

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUMEBLUE Prolonged-release tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V04CX	Other diagnostic agents	V Various → V04 Diagnostic agents → V04C Other diagnostic agents
Discover more medicines within V04CX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1826209
Country: FR	Base de données publique des médicaments	Identifier(s): 64311245
Country: IT	Agenzia del Farmaco	Identifier(s): 048994014
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091039
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100440291